Florida wins first FDA approval to import drugs from Canada

Pharmacist Thomas Jensen, looks over a prescription drug at the Rock Canyon pharmacy in Provo, Utah, May 9, 2019.George Frey | ReutersThe Food and Drug Administration on Friday approved Florida's plan to import cheaper prescription drugs from Canada, a first-in-the-nation move that could reduce costs for Americans but faces...

Read more...

Moderna stock jumps after Oppenheimer upgrade on pipeline potential

Artur Widak | Nurphoto | Getty ImagesShares of Moderna jumped more than 15% on Tuesday after Oppenheimer upgraded the stock to "outperform," saying the Covid vaccine maker could market five products by 2026.The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot....

Read more...

Moderna, Merck cancer vaccine reduces risk of skin cancer return

An exterior view of Moderna's clinical manufacturing facility. David L. Ryan | Boston Globe | Getty ImagesModerna and Merck's experimental cancer vaccine, when used in combination with Merck's blockbuster therapy Keytruda, reduced the risk of death or relapse in patients with the most deadly form of skin cancer after three...

Read more...

Vertex nonopioid painkiller posts positive midstage trial results

A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019.Brian Snyder | ReutersShares of Vertex Pharmaceuticals jumped Wednesday after the company's painkiller, which is being tested as an alternative to opioids, significantly decreased pain in a midstage trial.Those positive results for...

Read more...

Pfizer 2024 revenue, profit forecast disappoints

Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street's expectations, as it sees weak demand for its once-blockbuster Covid products. Pfizer also raised the target of its sweeping cost-cutting plan by $500 million, bringing the anticipated total to $4 billion.The company expects 2024...

Read more...

Patients on Eli Lilly drug regain weight after stopping it

Eli Lilly's drug tirzepatide was approved for weight loss by the FDA.Courtesy of Eli LillyPatients who took Eli Lilly's weight loss drug Zepbound regained around half the weight they shed after stopping the newly approved treatment for a year, according to data released Monday. The data, which represents the full...

Read more...